Clinical Trial Update: Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination Therapy

View source ↗

Summary

A completed clinical trial evaluating changes in total drug load and seizure frequency with Vimpat (lacosamide) in combination therapy for focal epilepsy with a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Focal Epilepsy

Drugs mentioned

• Vimpat (lacosamide)

Snippet

Sponsor: UCB Pharma GmbH | Conditions: Focal Epilepsy With and Without Secondary Generalization | Status: COMPLETED | Results posted: 2016-11-15